Note: Ingredients listed on restricted chemical lists
EC/CAS
231-791-2/7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
52
EC/CAS
500-038-2/25322-68-3
Name of the chemical
polyethyleneglycol
Concentration
10
EC/CAS
200-338-0/57-55-6
Name of the chemical
1,2-propanediol
Concentration
4
EC/CAS
202-222-5/93-14-1
Name of the chemical
Guaifenesin (INN)
Concentration
2
EC/CAS
201-069-1/77-92-9
Name of the chemical
Citric acid
Concentration
Acute Tox. 0.8
EC/CAS
208-534-8/532-32-1
Name of the chemical
Benzoic acid and its sodium salt
Concentration
0.2
EC/CAS
247-368-0/25956-17-6
Name of the chemical
Disodium 6-hydroxy-5-[(2-methoxy-4-sulphonato-m-tolyl)azo]naphthalene-2-sulphonate (17); (CI 16035)
Concentration
0.01
General Information
Revision date
2021-08-27
Product name
Robitussin Maximum Strength Cough and Chest Congestion DM Daytime (Project Accelerate)
Product Synonyms
Robitussin DM Max Daytime * Robitussin MS C&CC DM * H000011720 * WH-1719-0001
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
None
Section 2
2.1 Classification of the substance or mixture
The mixture has been assessed and/or tested for its physical, health and environmental hazards and the following classification applies.
EU Classification
Regulation (EC) No 1272/2008 as amended This mixture does not meet the criteria for classification according to Regulation (EC) 1272/2008 as amended. Hazard summary Not classified for health hazards. However, occupational exposure to the mixture or substance(s) may cause adverse health effects.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended
Hazard pictograms
None.
Signal word
None.
Hazard statements
The mixture does not meet the criteria for classification.
Prevention
Not available.
Response
Not available.
Storage
Not available.
Disposal
Not available.
Supplemental label elements
19 % of the mixture consists of component(s) of unknown acute oral toxicity. 31 % of the mixture consists of component(s) of unknown acute dermal toxicity. 29 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 41 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 41 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
2.3 Other hazards
This mixture does not contain substances assessed to be vPvB / PBT according to Regulation (EC) No 1907/2006, Annex XIII. The product does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
